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The fusion of HIV and SIV with biological membranes was studied by photosensitized activation of a hydrophobic
probe, [125I]iodonaphthylazide ([125I]INA), by a fluorescent lipid which is situated in the target membrane. Photosensitized
labeling of viral envelope-resident proteins occurs only upon their insertion into target membranes. Photosensitized
labeling as a result of HIV-1 Env-mediated cell fusion showed the same kinetics as aqueous dye transfer. We have for
the first time measured kinetics of HIV and SIV virus-cell fusion. HIV-1MN virions were about 10 less fusion active than
SIVmne virions. SIV inactivated by aldrithiol-2 retained fusion activity similar to that seen with untreated virus. The
relatively slow time course of SIV-cell fusion (t1/2  19 min) indicates that the fusion events are stochastic. This feature
provides a basis for understanding the mode of action of HIV/SIV entry inhibitors that target transition states. © 2002INTRODUCTION
Primate immunodeficiency viruses (human (HIV) and
simian immunodeficiency virus (SIV)) enter susceptible
cells by means of fusion of viral and cellular membranes,
a process mediated by the envelope glycoprotein com-
plex on the surface of the virion (Dimitrov, 2000). This
envelope protein is initially synthesized as the precursor
gp160, which is proteolytically cleaved into two nonco-
valently associated subunits, gp120 and gp41 (Kowalski
et al., 1987). Upon binding of gp120 to CD4 and a che-
mokine receptor on the target cell surface, gp120–gp41
undergoes conformational changes that promote mem-
brane fusion between virus and target cell (Doms, 2000).
When the envelope glycoprotein is expressed on the
surface of cells it mediates fusion at neutral pH with cells
bearing CD4 and the appropriate coreceptor (Lifson et
al., 1986). Some of the mechanistic features of HIV Env-
mediated fusion have been studied using cell fusion
assays based on dye redistribution between labeled HIV
Env-expressing cells and appropriate target cells (Mu-
noz-Barroso et al., 1998; Melikyan et al., 2000). Although
identification of the requisite receptors (Berger et al.,
1999), the role of receptor density (Doms, 2000), and the
well-understood conformational changes that result from
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cant progress in our understanding about the way HIV-1
and SIV virions gain entry into the cell, kinetic parame-
ters which govern fusion of intact HIV and SIV virions
with cells are still lacking.
We have developed methodologies to study fusion
of intact virions with cells based on photosensitized
activation by fluorescent lipid analogs of a hydropho-
bic probe, [125I]iodonaphthylazide ([125I]INA), that rap-
idly partitions into the membrane bilayer of cells (Pak
et al., 1994, 1997). Irradiation of cells containing
[125I]INA with ultraviolet (UV) light results in the forma-
tion of a reactive nitrene group capable of covalently
labeling adjacent proteins and lipids. [125I]INA labeling
of proteins and lipids can be confined to the site of
chromophore localization by photosensitized labeling.
The photosensitized labeling methodology involves
measurement of incorporation of [125I]INA into the viral
membrane-resident protein(s) as a result of virus–cell
fusion. Since it has been well established that the
envelopes of HIV and SIV grown in HLA-DR cell lines
are highly enriched with this membrane protein (Arthur
et al., 1992) we developed a method by which fusion of
HLA-DR HIV or SIV virions with appropriate HLA-DR
target cell membranes could be monitored by photo-
sensitized labeling of the viral HLA-DR as well as the
envelope glycoprotein. Using this methodology we
have been able for the first time to directly measureElsevier Science (USA)
Key Words: HIV; SIV; viral entry; membrane fusion; fluor
Room 216A, Miller Drive, Frederick, MD 21702-1201. Fax: (301) 846-6192.
E-mail: blumen@helix.nih.gov.
doi:10.1006/viro.2001.1237, available online at http://www.idealibrary.come; photolabeling; gp120; gp41; gp32.
fusion between HIV or SIV virions and appropriate
target cells.
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RESULTS
The experimental approach employed to measure fu-
sion of HIV-1 and SIV with cultured cells using photosen-
sitized labeling is illustrated in Fig. 1. The virions are
allowed to bind at 23°C and pH 7.4 to susceptible cells
via interactions between gp120, CD4 and coreceptor
(Berger et al., 1999), and possibly other surface mole-
cules (Ugolini et al., 1999; Hug et al., 2000; Liao et al.,
2000). The target cells are labeled with the fluorescent
lipid analog 3,3-dioctadecyloxacarbocyanine (DiO).
Since the photoreactive probe [125I]INA has a high parti-
tion coefficient for lipid bilayers relative to the aqueous
milieu (Bercovici and Gitler, 1978), both the membranes
of virions and target cells are labeled upon addition of
[125I]INA. The method relies upon the ability of a chro-
mophore, when excited by visible light, to activate
[125I]INA by an energy transfer mechanism, which re-
quires close proximity between the chromophore and the
[125I]INA, thereby limiting labeling to the site of chro-
mophore localization (Raviv et al., 1987, 1989, 1990;
Merezhinskaya et al., 1998). In the bound state prior to
fusion, the viral proteins are not in close proximity with
the chromophore, and therefore photoactivation by visi-
ble light will confine the covalent attachment of [125I]INA
exclusively to integral membrane proteins of the DiO-
labeled target membranes (Fig. 1, left). Upon incubation
of virus–cell complexes at 37°C, DiO becomes part of the
viral membrane as a result of fusion and therefore pho-
toactivation using visible light will result in covalent at-
tachment of [125I]INA to viral membrane-resident proteins
(Fig. 1, right). At different times following incubation at
37°C, samples are irradiated with visible light, the cells
are lysed, and the HIV or SIV Env as well other viral
envelope-resident proteins such as HLA-DR are isolated
from other radioactively labeled proteins by immunopre-
cipitation. The extent of radioactivity incorporated into
these proteins is then a quantitative measure of viral
fusion at the plasma membrane level.
To examine the specificity of the photosensitized la-
beling reaction we performed well-established cell fu-
sion experiments with HLA-DR NIH3T3 cells which ex-
press CD4 and CXCR4, as targets, or only CD4, as
controls. As effector cells we used the HIV-1LAI envelope
glycoprotein-expressing cell line TF228.1.16, which is de-
rived from the HLA-DR BJAB human B cell line.
The protocol is the same as that described for the
virus–cell fusion experiment in Fig. 1 except that we do
not include the preincubation step at 23°C. Figure 2A
FIG. 1. Experimental design of the photosensitized labeling experiment. Plasma membranes (green) of target cells bearing CD4 (black “pitchfork”)
and coreceptor (black “squiggle”) are labeled with the fluorescent lipid analog 3,3-dioctadecyloxacarbocyanine (DiO). Viral membranes (gray) bearing
gp120–gp41 (purple ball–orange “dumbbell”) and HLA-DR (blue objects) are not labeled with the dye. Other integral membrane proteins are not shown.
[125I]INA (orange balls) spontaneously partitions from the medium into viral and target membranes. In the bound state (left) only integral membrane
proteins of the DiO-labeled target membranes will react with [125I]INA following photoactivation (yellow balls) by visible light (see text). Upon incubation
of virus–cell complexes at 37°C, DiO becomes part of the viral membrane as a result of fusion (green continuous membrane) and therefore
photoactivation using visible light will result in covalent attachment of [125I]INA (yellow balls) to viral membrane-resident proteins (right). At different
times following incubation at 37°C, samples are irradiated with visible light, the cells are lysed, and the HIV or SIV Env, as well other viral
envelope-resident proteins such as HLA-DR, is isolated from other radioactively labeled proteins by immunoprecipitation. The extent of radioactivity
incorporated into these proteins is then a quantitative measure of viral fusion at the plasma membrane level.
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shows the extent of radioactivity incorporated into
HLA-DR at the indicated times of incubation between
effector and target cells. The values were normalized to
the amount of HLA-DR in each group. HLA-DR labeling
by INA as a result of specific fusion with NIH3T3 CD4X4
increases as a function of time, whereas the X4 control
cells show little photoincorporation of INA into HLA-DR
(Fig. 2B). Addition of 1 mM peptide inhibitor C34, which
interferes with gp41 hairpin formation (Chan et al., 1998),
resulted in 80% inhibition of photoincorporation of INA
into HLA-DR (Fig. 2C). These experiments show that the
photosensitized labeling methodology accurately mea-
sures the specific HIV-1 fusion reaction. In order to ex-
amine whether fusion measured by photosensitized la-
beling corresponds to the kinetics of the HIV-1 fusion
reaction, we performed in parallel measurements of dye
redistribution as a result of HIV-1 Env-mediated fusion
based on quantitative fluorescence microscopy. Figure 3
shows that the redistribution of calcein between cells
follows the same time course as [125I]INA incorporation
into HLA-DR, which depends on lipid (DiO) redistribution
between cells.
Since we established a reliable protocol to study HIV-1
Env-mediated fusion we proceeded to monitor kinetics of
fusion of intact HIV-1 virions with target cells using the
protocol outlined in Fig. 1. In the bound state HIV-1-
SupT1 complexes formed at 23°C, pH 7.4, were warmed
to 37°C and aliquots were taken after various amounts of
time for irradiation with visible light and analysis of
incorporation of [125I]INA into HLA-DR. Figure 4 shows
that after a delay of about 10 min, the INA incorporation
into HLA-DR increased with time, reaching a maximum
at about 30 min. The decline in HLA-DR labeling after 30
min is presumably the result of routing DiO and HLA-DR
into different intracellular trafficking pathways.
Since HIV-1 virions contain low amounts of Env (about
10 trimers per virion; L. E. Henderson, personal commu-
nication) they exhibit a low fusion activity. These exper-
iments therefore required incubation of high concentra-
tions of virus (about 0.2 mg/ml capsid) with high concen-
tration of cells (3  108 cells/0.5 ml). A more dilute HIV-1
suspension (10 ml) required for studies with attached
cells did not yield sufficient fusion events to obtain mea-
surable [125I]INA incorporation into HLA-DR. To obtain a
measurable signal we irradiated the cell suspension for
20 s using a 400-mW laser beam focused on 1 cm2 (133
FIG. 2. Photolabeling of HLA-DR as a result of HIV-1 Env-mediated cell fusion. (A) At the indicated times of incubation between HLA-DR TF228.1.16
effector cells and HLA-DR 3T3 CD4/CXCR4 target cells, samples were irradiated, and the HLA-DR was immunoprecipitated and subjected to Western
(ECL) and autoradiography. (B) The photolabeling of HLA-DR as a result of cell fusion as a function of the time of incubation between the TF228 and
the 3T3 CD4X4 or 3T3 CD4. (C)The photolabeling of HLA-DR obtained upon 2 h incubation TF228 and 3T3 CD4X4 or 3T3 CD4 in the presence (right)
or absence (left) of 1 mM C34. The arbitrary units on the y axis in B and C refer to the amount of immunoprecipitated radioactive HLA-DR, quantified
by phosphoimaging, normalized to the total amount of immunoprecipitated HLA-DR quantified by ECL on Western blots.
FIG. 3. Calcein redistribution versus photosensitized labeling. The
fusion between 3T3 CD4X4 cells and TF228 cells was assessed using
in parallel calcein redistribution and photolabeling of HLA-DR. Three
independent experiments of photosensitized labeling (PSL) identical to
that described in Fig. 1 were plotted. The signal was normalized to the
signal obtained upon 2 h of incubation to 100%. In parallel to PSL-3, the
redistribution of calcein loaded into TF228 to 3T3 CD4X4 cells was
measured as described under Materials and Methods.
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mW/cm2/min). The strong laser beam focused on the cell
suspension in a small volume may induce the formation
of INA radicals generated by local heat production, pre-
sumably resulting in nonspecific covalent attachment of
[125I]INA to the viral membrane proteins. The incorpora-
tion of [125I]INA into HLA-DR of bound virions prior to
fusion (Fig. 4, zero time) was therefore relatively high.
The poor signal to noise led us to pursue our studies
with SIV.
To monitor fusion with attached cells we proceeded
with SIVmne virions, which contain 10 more Env than
HIV-1MN (E. Chertova, personal communication) and are
therefore highly fusogenic. SIV virions were bound to
Ghost 345 cells at 23°C for 30 min, the plates were
washed with fresh medium, overlaid with medium pre-
warmed at 37°C, and then put into the 37°C incubator.
After a given interval of time the dishes were taken out,
and the cell lysate was analyzed for incorporation of
[125I]INA into HLA-DR. We irradiated the plated cell con-
figuration for 60 s with a 5-W laser beam over an area of
144 cm2 (11 mW/cm2/min). The power applied to the
system was an order of magnitude lower in this config-
uration compared to the cells in suspension, and conse-
quently there was little nonspecific attachment of
[125I]INA to the viral membrane proteins, resulting in
much better signal-to-noise ratios. Figure 5 shows a
relatively low background incorporation of [125I]INA into
HLA-DR at 23°C (zero time). However, when overlaid
with the medium prewarmed at 37°C the incorporation of
[125I]INA into HLA-DR increased as a function of time
reaching about 4 the background level after 40 min
with a t1/2 of 19 min (Fig. 5).
In order to examine the specificity of the SIV-cell fusion
reaction, we examined [125I]INA incorporation into
HLA-DR using various engineered cell lines as targets.
Previous studies based on gene reporter assays indicate
that SIVmne uses CCR5 and not CXCR4 (Chen et al.,
1998). With the Ghost 345 cells, which express CXCR4
and CCR5, the incorporation of [125I]INA into HLA-DR was
rapid and increased with time. However, Ghost P cells,
which bear CD4 and very low endogenous amounts of
CXCR4, showed little incorporation of [125I]INA into HLA-
DR. HeLa CD4 cells, which bear CXCR4, did show
[125I]INA incorporation above background. However, in
contrast to NIH3T3 CD4R5, NIH3T3 CD4 cells, which do
not express known coreceptors, showed no [125I]INA in-
corporation into HLA-DR above background (Fig. 6).
Since SIVmne contains sufficient Env to monitor
[125I]INA incorporation into the transmembrane (TM) SIV
Env, gp32, we compared [125I]INA incorporation into this
protein to that into HLA-DR. The SIVmne used in this
experiment was clone B4P (Benveniste et al., 1990),
which exhibits higher activity on the Ghost P cells than
the E11S clone (compare Figs. 6 and 7 for Ghost P).
Nevertheless the amounts of HLA-DR and Env incorpo-
ration were similar even into the Ghost P cells (Fig. 7).
Incubation of the virus with Ghost 345 cells for 40 min at
23°C did not lead to any [125I]INA incorporation into either
gp32 or HLA-DR. We also tested the fusion activity of
SIVmne treated with 2,2-dithiodipyridine (aldrithiol-2),
which inactivates infectivity of retroviruses by covalently
modifying the nucleocapsid zinc finger motifs (Rossio et
al., 1998). Figure 7 shows that aldrithiol-treated virus was
as active as the untreated control, indicating that the
FIG. 5. Kinetics of fusion of SIV with Ghost 345 cells. HLA-DR Ghost
345 cells were plated onto 10-cm-diameter petri dishes. HLA-DR SIV
mne/HuT78 CL.B4P virions were allowed to bind 30 min at room
temperature, pH 7.4. Unbound virions were removed, the plates were
overlaid with medium prewarmed at 37°C and put into a 37°C incuba-
tor. After indicated times in the incubator, the plates were irradiated
and the photolabeling of HLA-DR was measured as described. The
arbitrary units on the y axis refer to the amount of immunoprecipitated
radioactive HLA-DR, quantified by phosphoimaging, normalized to the
total amount of protein. The data (circles) have been fit (line) to the
equation y  y 0  a (1  exp(bt)) using SigmaPlot2000 (SPSS
Science, Chicago, IL). The parameter fit yields b  0.0364/min or t 1/ 2
 19 min.
FIG. 4. Photolabeling of HLA-DR as a result of HIV-1 fusion. HLA-DR
HIV-1 (MN)cl.4/T1 virions were allowed to bind with HLA-DR SupT1 for
2 h at room temperature, pH 7.4. The preformed complexes were
aliquoted and warmed to 37°C. At the indicated times of incubation at
37°C, the samples were irradiated and the photolabeling of the immu-
noprecipitated HLA-DR was measured as described. The arbitrary
units on the y axis refer to the amount of immunoprecipitated radioac-
tive HLA-DR, quantified by phosphoimaging, normalized to the total
amount of immunoprecipitated HLA-DR quantified by ECL on Western
blots.
246 RAVIV ET AL.
inactivation procedure did not affect the activity of SIV
Env.
DISCUSSION
Using the photosensitized labeling techniques we
have for the first time been able to directly measure HIV
and SIV virus–cell fusion. This method relies upon the
ability of certain chromophores, when excited by visible
light, to activate [125I]INA by an energy transfer mecha-
nism, which requires close proximity between the chro-
mophore and [125I]INA, thereby limiting labeling to the
site of chromophore localization (Raviv et al., 1987, 1989,
1990; Merezhinskaya et al., 1998). Photoactivation using
visible light of target membranes labeled with DiO and
[125I]INA, to which unlabeled virions are bound, results in
labeling of virus-resident proteins which have become
part of the target membrane (Pak et al., 1994, 1997;
Merezhinskaya et al., 1998; Raviv et al., 2000). In these
experiments the target membranes and not the virions
are labeled with the fluorescent dye. Previous measure-
ments of HIV and SIV fusion were based on fluorescence
dequenching assays (Hoekstra et al., 1984). For these
assays high concentrations of lipid fluorophore are in-
corporated into the viral membrane, giving rise to “micro-
crystals” associated with the viral membrane. Moreover,
contamination of the virus stocks by inactive particles or
debris complicates the analysis by nonspecific de-
quenching of the probe (Volsky, 1990; Duzgunes et al.,
1991; Dimitrov et al., 1992). On the other hand, cells
labeled with lipid probes do not redistribute their dye
nonspecifically to unlabeled cells even at long times of
incubation (Munoz-Barroso et al., 1998; Melikyan et al.,
2000).
We tested the specificity of the photosensitized label-
ing technique using well-established cell fusion assays.
Figure 2 shows that [125I]INA incorporation into HLA-DR
occurs only when the appropriate fusion partners (cells
expressing X4-utilizing virus and CD4- and X4-express-
ing cells) are co-incubated. This fusion was blocked by
the well-known inhibitor for viral entry, C34 (Chan et al.,
1998). Moreover, fusion monitored by [125I]INA incorpora-
tion into HLA-DR exhibited kinetics similar to those of
fusion monitored by transfer of aqueous dyes between
cells (Fig. 3). The specificity of [125I]INA incorporation into
HLA-DR as a result of SIV–cell fusion was also demon-
strated by the fact that only background incorporation
was seen when SIV was incubated with NIH3T3 CD4
cells, whereas high amounts of incorporation were seen
when CCR5 was present on these cells (Fig. 6). This
indicates that binding of virus to CD4 on target cells by
itself does not give rise to photosensitized labeling of
virus-resident proteins.
Our initial kinetic experiments with HIV-1MN required
incubation of high concentrations of virus (about 0.2
mg/ml capsid) with 3  108 cells in suspension. The
laser beam focused on the small tube resulted in sub-
stantial nonspecific incorporation of [125I]INA into
HLA-DR and a relatively low signal-to-noise ratio (see
Fig. 4). If the HIV-1 virus was further diluted to about 0.08
mg/ml capsid for incubation with attached cells, no
[125I]INA incorporation into HLA-DR was detected. By
contrast, [125I]INA incorporation into HLA-DR was de-
FIG. 6. Fusion of SIV with engineered cells lines. The different
HLA-DR target cells were plated onto 10-cm-diameter petri dishes.
HLA-DR SIVmne/HuT78 CL.E11S virions or SIVmne/HuT78 CL.B4P
virions (in the case of the NIH3T3 cells) were allowed to bind 30 min at
room temperature, pH 7.4. Unbound virions were removed and the
dishes were put into a 37°C incubator. After 0, 20, and 40 min, in the
case of Ghost cells, and 0 and 40 min, in the case of HeLa and NIH3T3
cells, in the incubator, the plates were irradiated and the photolabeling
of the immunoprecipitated HLA-DR was measured by autoradiography.
The signals obtained by measuring [125I]INA-labeled HLA-DR were
normalized to the signals obtained upon 40 min of incubation to 100%
and labeled on the y axis as [125I]INA-labeled HLA-DR (%).
FIG. 7. Incorporation of [125I]INA into SIV gp32 and HLA-DR. The
different HLA-DR target cells were plated onto 10-cm-diameter
dishes. HLA-DR SIVmne/HuT78 CL.B4P untreated virions or SIVmne/
HuT78 CL.E11S virions treated with aldrithiol (E11S ALD) were allowed
to bind 30 min at room temperature, pH 7.4. Unbound virions were
removed and the dishes put into a 37°C incubator or left at room
temperature (RT). After the indicated times, the plates were irradiated
and the photolabeling of the immunoprecipitated HLA-DR or the immu-
noprecipitated gp32 was measured by autoradiography. The signals
obtained by measuring [125I]INA-labeled HLA-DR or [125I]INA-labeled
gp32 were normalized to the signals obtained upon 40 min of incuba-
tion to 100% and labeled on the y axis as [125I]INA-labeled HLA-DR or
[125I]INA-labeled gp32 (%).
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tected when SIVmne at concentrations as low as 0.006
mg/ml capsid was incubated with attached target cells
(Figs. 5–7). The enhanced fusogenic activity of SIV Env is
presumably due to relatively high amounts of Env incor-
poration in SIVmne (Benveniste et al., 1990; Arthur et al.,
1998) and possibly due to the higher fusogenic activity of
the SIV Env. The fusion of SIVmne with cells shows a very
steep temperature dependence in that no fusion was
observed at 23°C, even after 40 min of incubation (Figs.
5–7). The threshold for the onset of SIV virus–cell fusion
of about 32°C (data not shown) is similar to that seen for
HIV-1-mediated cell fusion (Frey et al., 1995; Jernigan et
al., 2000).
Even though SIVmne does not appear to use CXCR4
according to assays based on gene reporters (Chen et
al., 1998) we do observe incorporation of [125I]INA into
HLA-DR when SIVmne was incubated with cells bearing
CD4 and CXCR4 (Figs. 6 and 7). This indicates that lack
of CXCR4 usage by this virus is not absolute and that the
photosensitized labeling method is capable of detecting
this CXCR4 usage. Since photosensitized labeling will
occur when DiO is transferred from cell to virus, [125I]INA
incorporation into HLA-DR may occur under conditions
under which small transient fusion pores are formed.
Gene reporter assays require formation of fusion pores
sufficiently large and sustained to allow delivery of the
nucleocapsid into the cell. Therefore, it is possible that
CXCR4 provides a trigger for the initial fusion event,
which is not strong enough to complete the fusion reac-
tion.
Although incubation of HIV Env-expressing cells with
target cells at 23°C does not lead to fusion, Melikyan et
al. (2000) showed that in this “temperature-arrested
state” the gp41 is sensitive to the C-terminal peptides,
indicating that the N-terminal triple-stranded coiled coil
is accessible under these conditions. Moreover, they
provide evidence that formation of the six-helix bundle is
coincident with membrane fusion. According to their
model the fusion peptide becomes exposed and inserts
into the target membrane in this intermediate state. By
measuring incorporation of [125I]INA into both HLA-DR
and SIV gp32 we can examine whether gp32 insertion
into the target membrane takes place prior to actual
fusion. If this were the case we would observe prefer-
ential labeling of gp32 (i.e., its fusion peptide) over HLA-
DR, whose transmembrane anchor will be labeled only
under conditions of actual fusion. Since Fig. 7 shows no
preferential labeling of gp32 at 23°C, the data may sug-
gest that no fusion peptide insertion takes place under
these conditions. However, since our assay might not be
sufficiently sensitive to measure insertion prior to fusion,
we will be pursuing more detailed studies in the future to
establish this conjecture.
We have demonstrated that the photosensitized label-
ing approach could provide unique information regarding
the HIV and SIV fusion. A useful observation is that SIV
inactivated by aldrithiol-2 retained fusion activity indis-
tinguishable from that seen with untreated virus. Thus,
the reduced biohazard will make it possible to study the
SIV or HIV fusion process in a regular laboratory setting
using inactivated virus. The low efficiency of HIV and SIV
fusion results in the insertion, at any given time, of only
a small fraction of the total TM or HLA-DR molecules into
the target cell membrane. Therefore, relatively large
amounts of virus and target cells are needed in the assay
in order to obtain a measurable incorporation of [125I]INA
into the inserted viral envelope proteins. The low specific
radioactivity of the INA preparation (1 Ci/mmol), which
proved advantageous in previous studies, further re-
duced the magnitude of the signal and the sensitivity of
the assay. The application of this technique to routine
assays of viral entry will require an increase in the
sensitivity of that assay, which can be accomplished by
employing chemiluminescence-enhanced immunode-
tection of nonradioactive iodonaphthylazide using anti-
bodies specific for this probe. Further development of
this methodology will make it possible to gain crucial
information regarding mechanisms of HIV and SIV entry.
The most significant finding of this paper is that we
have for the first time been able to directly measure the
kinetics of HIV and SIV virus–cell fusion. We find that SIV
fusion reaches a maximum with a t1/2 of 19 min (Fig. 5).
For influenza virus fusion we measured a t1/2 of 0.3 min at
optimal pH and temperature (Krumbiegel et al., 1994),
which is about two orders of magnitude lower than that
for HIV/SIV fusion. In the case of acid-activated viruses
triggering occurs rapidly and synchronously, so that all
viral envelope proteins are activated within a short pe-
riod, leading to rapid fusion kinetics. By contrast, the CD4
and coreceptor-induced triggering events leading to
HIV-1 Env-mediated fusion are presumably stochastic,
leading to a much slower fusion kinetics. This finding
has important implications with respect to the mode of
action of HIV/SIV entry inhibitors. According to a widely
accepted “viral hairpin” model for HIV/SIV Env-mediated
membrane fusion, the gp41 core forms a stable six-helix
bundle in which the fusion peptide and transmembrane
domain of gp41 are now oriented at the same end of the
molecule (Chan et al., 1997; Weissenhorn et al., 1997).
Synthetic C peptides (peptides corresponding to the C
helix) potently inhibit HIV-1 entry with IC50 values in the
nanomolar range (Jiang et al., 1993; Wild et al., 1993).
Those peptides presumably bind to the prehairpin
groove, thereby interfering with the formation of the viral
hairpin (Chen et al., 1995; Chan et al., 1998). Given that in
the presumed prehairpin state of the intact gp41 the
NH2-terminal leucine/isoleucine zipper and C-helical do-
mains are present at very high concentration it is some-
what surprising that the synthetic C peptides are capable
of inhibiting the formation of the six-helix bundle at rel-
atively low (nM) concentrations. The lack of synchrony in
the case of HIV/SIV–cell fusion therefore provides an
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opportunity for the C-terminal peptides to bind to the
prehairpin grooves, which become transiently exposed
following CD4 and coreceptor-induced triggering of
HIV-1 Env (Furuta et al., 1998; Melikyan et al., 2000; Gallo
et al., 2001). The relatively slow kinetics of intact HIV/
SIV–cell fusion provides a basis for understanding the
mode of action of HIV/SIV entry inhibitors, which target
transition states, and holds out the possibility that neu-
tralizing antibodies can be raised against “fusion-com-
petent” HIV vaccine immunogens (LaCasse et al., 1999).
MATERIALS AND METHODS
Materials
Antibodies and their sources were as follows: anti-
HLA-DR IgG L243 (mAb from Elena Chertova), anti-
HLA-DR IgG DA6-147 (mAb from Paul Roche), and anti-
Gp32 IgG (rabbit polyclonal Ab from Raoul Benveniste).
[125I]INA (300 mCi/mmol) was purchased from Lofstrand
Laboratories (Gaithersburg, MD). All other biochemicals
used were of the highest purity available and were ob-
tained from regular commercial sources.
Viruses
HIV-1MN/H9 clone 4 was propagated in H9 cells, as
described previously (Ott et al., 1995). SIVmne was ob-
tained from supernatants of the cloned E11S cell lines,
derived from a culture of HuT-78 cells infected with
SIVmne (Benveniste et al., 1990). Concentrated virus
preparations were produced by sucrose gradient band-
ing in a continuous-flow centrifuge (Bess et al., 1997).
Inactivation of SIV by treatment with aldrithiol-2 was
performed as described (Rossio et al., 1998).
Cell cultures
Ghost-345 cells (derived from human osteosarcoma
cells) that stably express CD4, as well as CXCR4 and
CCR5, and NIH3T3 CD4/X4 were obtained from Dan
Littman and Vineet KewalRamani. TF228 cells derived
from the BJAB human B cell line and that stably express
the HIV-1LAI envelope glycoprotein (Jonak et al., 1993)
were from Zdenka L. Jonak (Smith-Kline & Beecham, King
of Prussia, PA). SupT1 (human CD4-expressing T-lym-
phoblastic cell line) and TF228 were grown in RPMI
supplemented with 10% fetal bovine serum (FBS) (Life
Technologies, Inc., Rockville). NIH3T3 CD4 cells were
grown in Dulbecco’s modified Eagle’s medium  10%
FBS (D10). NIH3T3 CD4/X4 cells were grown in D10  3
mg/ml puromycin. Ghost 345 cells were grown in D10 
500 mg/ml G418  100 mg/ml hygromycin  1 mg/ml
puromycin. All the cells were grown in the presence of
penicillin and streptomycin.
Labeling of the target cells
The fluorescent lipid DiO (Molecular Probes, Eugene,
OR) was diluted in 50% Diluent C (Sigma–Aldrich, St.
Louis, MO) and 50% serum-free RPMI (RPMI) to a final
concentration of 50 mM. After two washes in RPMI the
cells were incubated in the DiO solution for 30 min at
room temperature. They were then washed once with
clear RPMI and further incubated 30 min in medium at
room temperature. They were then washed three times
with PBS, in which they were finally resuspended. At this
point [125I]INA (1 Ci/mmol) was added in the amount of 10
mCi for each experimental group. Upon 20 min incuba-
tion in the dark, the cells were washed with PBS and
subsequently used for the photolabeling experiment.
Measurement of fusion by photo-sensitized labeling
The HLA-DR virions are incubated with the HLA-DR
target cells labeled with DiO and [125I]INA for binding at
room temperature (see legend to Fig. 1 for a detailed
description). In the case of HIV-1, 1 ml virus (0.79 mg/ml
capsid) was added to 3  108 SupT1 cells in 3 ml. In
case of SIVmne, 0.2 ml of virus (0.084 mg/ml capsid) was
added to 3 ml medium overlaid on attached cells. The
unbound virions were then removed and the samples
subjected to fusion at the desired temperature. At de-
fined times cells were irradiated with an argon laser
(Lexel Laser, Inc., Freemont, CA) in the multiline mode of
488/514 nm. Suspension cells were irradiated horizon-
tally for two consecutive 10-s periods with a beam of 400
mW that was passed through a UV cut-off filter and
focused on an area of 1 cm2 (133 mW/cm2/min). Plated
cells were irradiated for 60 s vertically using a 5-W beam
focused on an area of 144 cm2 (11 mW/cm2/min). The
cells were then collected and lysed (2% Triton X-100 in
Tris-buffered saline (TBS; 50 mM Tris, 138 mM NaCl, 2.7
mM KCl, pH 8) containing protease inhibitors) for 2 h at
4°C. The insoluble material was spun down at 15,000
rpm for 15 min in a Eppendorf microcentrifuge. The
supernatant was then diluted twice in TBS and total
protein was measured using the BCA protein determina-
tion reagent (Pierce, Rockford, IL). Samples were sub-
jected to immunoprecipitation using L243 (for HLA-DR)
or anti-SIV gp32 for the SIV Env. Upon overnight incuba-
tion with the respective antibody, protein G-agarose was
added for 2 h and washed five times with TBS containing
1% Triton X-100. Proteins were separated by 14% SDS–
PAGE and transferred to nitrocellulose membranes. Blots
were incubated for 1 h in PBST (phosphate-buffered
saline, 0.2% Tween 20) containing 5% powdered skim
milk. Membranes were incubated for 2 h with the primary
antibody in a 3% BSA solution containing 0.2% Tween 20
and for 1 h 30 min with a peroxidase-conjugated sec-
ondary antibody in PBST. Immunoreactivity was detected
by using an ECL kit (Amersham, Piscataway, NJ) and an
imaging system with high dynamic range (Bio-Rad GS
505 Molecular Imager System, Hercules, CA). The blots
were then exposed to PhosphorImager screens and
quantitated using a Storm system (Molecular Dynamics,
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Sunnyvale, CA) and the Image Quant software (Molecu-
lar Dynamics).
HIV-1 envelope glycoprotein-mediated cell–cell fusion
For the photo-sensitized labeling experiments HLA-
DR TF228.1.16 effector cells and DiO-labeled HLA-DR
target cells were loaded with [125I]INA and incubated for
various times at 37°C. The plates were irradiated for 60 s
with a 5-W laser beam over an area of 144 cm2 (11
mW/cm2/min) and incorporation of [125I]INA into HLA-DR
was measured as described above. For the dye redistri-
bution experiments target cells were labeled with the
cytoplasmic dye 5- and 6-([(4-chloromethyl)benzoyl]-
amino)tetramethylrhodamine (CMTMR) at a concentra-
tion of 1.5 mM for 1 h at 37°C. Envelope-expressing cells
were labeled with calcein AM at a concentration of 1 mM
for 1 h at 37°C. Calcein-labeled effector cells were cocul-
tured with CMTMR-labeled target cells for 2 h at 37°C,
and dye redistribution was monitored microscopically as
described previously (Munoz-Barroso et al., 1998). The
extent of fusion was calculated as percent fusion  100
 number of bound cells positive for both dyes/number
of bound cells positive for CMTMR.
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